OMERS Administration Corp’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,666
Closed -$2.92K 357
2022
Q4
$2.92K Hold
11,666
﹤0.01% 246
2022
Q3
$1K Hold
11,666
﹤0.01% 386
2022
Q2
$1K Hold
11,666
﹤0.01% 436
2022
Q1
$2K Hold
11,666
﹤0.01% 464
2021
Q4
$7K Hold
11,666
﹤0.01% 390
2021
Q3
$7K Buy
+11,666
New +$9.08K ﹤0.01% 432

OMERS Administration Corp's EBACW Position: Q1 2023 in Review

OMERS Administration Corp sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 11,666 shares — an estimated $2.92K sold.

OMERS Administration Corp first reported a position in EBACW in Q3 2021 and held it in 6 quarters. The position peaked at $7K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • OMERS Administration Corp reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • OMERS Administration Corp sold 11,666 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $2.92K.
  • OMERS Administration Corp first reported a position in European Biotech Acquisition Corp. Warrant in Q3 2021 and held it in 6 quarters.
  • OMERS Administration Corp's European Biotech Acquisition Corp. Warrant position peaked at $7K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on OMERS Administration Corp's 13F filing for Q1 2023, filed 12 May 2023.